Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-130258
Filing Date
2024-11-22
Accepted
2024-11-22 16:33:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 evoke_nov_24_atm_supplem.htm 424B5 12010
2 GRAPHIC img73854561_0.jpg GRAPHIC 19583
  Complete submission text file 0000950170-24-130258.txt   40138
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-281840 | Film No.: 241490316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)